11 Result(s)
within
Rocio Perez-Iglesias
-
Article
Open AccessRemission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate
Neuroimaging studies in schizophrenia have linked elevated glutamate metabolite levels to non-remission following antipsychotic treatment, and also indicate that antipsychotics can reduce glutamate metabolite ...
-
Article
Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non-affective psychosis
The use of second-generation antipsychotics (SGA) has been associated with metabolic changes. However, there are differences in the metabolic profile between SGAs. We have previously observed that ziprasidone ...
-
Article
Common genetic variants influence human subcortical brain structures
Genome-wide association studies are used to identify common genetic variants that affect the structure of selected subcortical regions of the human brain; their identification provides insight into the causes ...
-
Article
Treatment of first-episode non-affective psychosis: a randomized comparison of aripiprazole, quetiapine and ziprasidone over 1 year
Discontinuation of antipsychotic treatment at early phases increases the risk of poor adherence to maintenance drug therapy. Differences among antipsychotics in terms of effectiveness may determine a good adhe...
-
Article
Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone
The initially postulated superior neurocognitive effectiveness of second-generation antipsychotics is currently under debate.
-
Article
Homocysteine and cognition in first-episode psychosis patients
In the last years, there has been growing evidence linking elevated homocysteine levels with cognitive dysfunction in several neurological and neuropsychiatric diseases. The aim of the present study was to inv...
-
Article
Long-term (3-year) effectiveness of haloperidol, risperidone and olanzapine: results of a randomized, flexible-dose, open-label comparison in first-episode nonaffective psychosis
To enhance the effectiveness of antipsychotics in first-episode psychosis is crucial in order to achieve the most favourable prognosis. Difference in effectiveness between antipsychotics is still under debate.
-
Article
Antipsychotic-Induced Weight Gain in Chronic and First-Episode Psychotic Disorders
Antipsychotic-induced weight gain is an important issue in the treatment of psychotic illnesses, and affects 80% of individuals being treated with antipsychotic drugs. However, the true dimension of weight gai...
-
Article
Cognitive functioning and negative symptoms in first episode schizophrenia: Different patterns of correlates
Negative symptoms of schizophrenia have been related to disturbances of executive functions, memory, attention and motor functioning. The executive functions dimension comprises a variety of cognitive subproce...
-
Article
Open AccessSmoking among pregnant women in Cantabria (Spain): trend and determinants of smoking cessation
Cantabria (Spain) has one of the highest prevalence of smoking among women of the European Union. The objectives are to assess the trend of smoking during pregnancy in a five-year period and the determinants o...
-
Article
Cognitive functioning in the early course of first-episode schizophrenia spectrum disorders
The aim of this study was to examine possible cognitive changes throughout the early course of schizophrenia spectrum disorders.
